Clinic/Industry collaboration for implementation of advanced immune therapies

Debate about collaboration for the total treatment

  • TBD

1 day course

Danish

1.350,- DKK ex VAT
(app. 182,- EUR ex VAT)
50% DISCOUNT FOR PUBLIC INSTITUTIONS

At the moment there are no available dates for this course.

Summary

The clinic and its suppliers of medicines now has a new shared point of collaboration. Right now, more than 30 treatment possibilities are in the stage of late clinical development, and within a few years, clinics will have access to brand new tools.

The possibilities are created through modern gene technology, and the individual patient will become an integral part of the treatment.

In this time of change, possibilities emerge for a brand-new model for both business and collaboration in which the total treatment is in play.

On this online course, Inge Marie Svane presents her view on what is needed from the industry in order for the clinics to adopt immune therapy/CAR-T. In addition, possibilities and challenges in the collaboration between clinic and treatment supplier are discussed.
 

Key words

  • Immune therapy
  • CAR-T
  • Gene technology
  • Gen Tech

What you will learn

  1. What is needed from the industry in order for the clinics to adopt immune therapy/CAT-T?
  2. What possibilities and challenges exist in the collaboration between clinic and treatment supplier?

What your company will get

  1. An employee who is aware of a clinic’s considerations with starting to use immune therapy/ CAT-T

WANT TO KNOW MORE ABOUT THIS COURSE?

Contact Client Manager Birger Flinthagen at +45 39 15 09 06

Send an email